Barriers and facilitators to starting and staying on ketogenic diet therapy for children with epilepsy: A scoping review
Clinical Nutrition ESPEN · 2025
DOI: 10.1016/j.clnesp.2025.02.020 ↗Kurz gefasst
Scoping Review in der Zeitschrift Clinical Nutrition ESPEN, 2025. Verfasst von Humzah Hameed und 2 weiteren Autor:innen. Beteiligte Einrichtung: UCL Medical School, 74 Huntley Street, WC1E 6DE, London, UK. Hauptthemen laut MEDLINE: Diet, Ketogenic, Epilepsy, Drug Resistant Epilepsy, Patient Compliance. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 94 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Rosetrees, National Institute for Health and Care Research, National Institute for Health Research Research for Patient Benefit.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
BACKGROUND: Ketogenic diet therapy (KDT) is a group of high-fat, low-carbohydrate, moderate protein diets that are an effective treatment option for children and young people with drug-resistant epilepsy. However, 45 % of patients referred to start KDT, who are medically eligible to do so, do not start diet. A further 25 % discontinue KDT before 3 months. AIM: To explore barriers and facilitators for children and young people with epilepsy to start or continue on KDT, and their families. Based on the Participants, Concept and Context (PCC) framework, this review included children and young people with drug-resistant epilepsy (P) referred for KDT (C) or their families, who had expressed their views regarding barriers or facilitators for starting or continuing on dietary treatment (C). METHODS: This scoping review followed JBI methodology. Identified barriers/facilitators were matched to relevant sections of the 'Capability, Opportunity, Motivation - Behaviour' (COM-B) model and organised according to the phases of the patient journey: pre-diet, diet initiation and maintenance. RESULTS: 60 studies were included. 15 barriers and 9 facilitators were identified for the pre-diet and initiation stages; 19 barriers and 14 facilitators were identified for staying on KDT once the diet had been fully established. CONCLUSIONS: Barriers and facilitators for children and young people who are considering starting KDT, or who are currently following KDT, and their families, are multifactorial and extend beyond the level of the individual. Our findings will help identify areas to prioritise for interventions to support patients and their families.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- UCL Medical School, 74 Huntley Street, WC1E 6DE, London, UK.
- Ketogenic Metabolic Therapy Laboratory, Department of Public Health, Experimental and Forensics Medicine, University of Pavia, 27100 Pavia, Italy; Laboratory of Food Education and Sport Nutrition, Department of Public H…
- UCL Great Ormond Street Institute of Child Health, 30 Guilford Street, WC1N 1EH London, UK; Great Ormond Street Hospital for Children, Great Ormond Street, WC1N 3JH, London, UK.
Förderung
- Rosetrees
- National Institute for Health and Care Research
- National Institute for Health Research Research for Patient Benefit
Zitieren
APA
Hameed, H., Lopes Neri, L. C., & Schoeler, N. (2025). Barriers and facilitators to starting and staying on ketogenic diet therapy for children with epilepsy: A scoping review. Clinical Nutrition ESPEN. https://doi.org/10.1016/j.clnesp.2025.02.020
Vancouver
Hameed H, Lopes Neri LC, Schoeler N. Barriers and facilitators to starting and staying on ketogenic diet therapy for children with epilepsy: A scoping review. Clinical Nutrition ESPEN. 2025. doi:10.1016/j.clnesp.2025.02.020
BibTeX
@article{Hameed2025,
author = {Hameed, Humzah and Lopes Neri, Lenycia de Cassya and Schoeler, Natasha},
title = {Barriers and facilitators to starting and staying on ketogenic diet therapy for children with epilepsy: A scoping review},
journal = {Clinical Nutrition ESPEN},
year = {2025},
doi = {10.1016/j.clnesp.2025.02.020}
}
EUVIMED